Recent updates in pediatric diffuse glioma classification: insights and conclusions from the WHO 5th edition
- PMID: 39440342
- PMCID: PMC11493159
- DOI: 10.25122/jml-2023-0515
Recent updates in pediatric diffuse glioma classification: insights and conclusions from the WHO 5th edition
Abstract
The World Health Organization (WHO) Central Nervous System (CNS) Tumors Classification 5th edition (2021) integrates both molecular and histopathological criteria for diagnosing glial tumors. This updated classification highlights significant differences between pediatric and adult gliomas in terms of molecular characteristics and prognostic implications. The 5th edition comprises a new category of pediatric-type diffuse low-grade glioma (PDLGG) and pediatric-type diffuse high-grade glioma (PDHGG), classified mainly based on genetic alterations and histopathological features. We reviewed the microscopy, diagnostic molecular pathology, and prognosis of various tumors under the categories PDLGG and PDHGG. The review also addresses the need for clarification concerning overlapping diagnostic features. PDLGG are characterized by diffuse growth, low-grade morphology, and MYB/MYBL1(MYB Proto-Oncogene Like 1) gene fusion or mitogen-activated protein kinase (MAPK) pathway alterations. In contrast, PDHGG is described by diffuse growth, high-grade morphology, and increased mitosis and often shows alterations of histone gene resulting in epigenetic alterations, which contrasts with common isocitrate dehydrogenase (IDH) mutation and epidermal growth factor receptor (EGFR) amplification seen in adult-type high-grade glioma.
Keywords: H3G34-mutant; H3K27-altered; MAPK pathway alterations; MYB/MYBL1 fusion; WHO CNS 2021; angiocentric glioma; diffuse astrocytoma; hemispheric glioma; pediatric-type high-grade glioma.
© 2024 The Author(s).
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Hawkins CE, Blumcke I, Capper D, Ellison DW, Jones DTW, Najm I, et al. Diffuse Astrocytoma, MYB- or MYBL1- altered. WHO Classification of Tumours of the Central Nervous System 5th ed. In: Cree IA, Lokuhetty D, Peferoen LAN, White VA, editors. WHO Classification of Tumours Editorial Board International Agency for Research on Cancer (IARC), Lyon. Vol. 6. 2021. pp. 56–58.
-
- Ellison DW, Jones DTW, Ligon KL, Preusser WM, Rosenblum MK. Angiocentric Glioma. In: Cree IA, Lokuhetty D, Peferoen LAN, White VA, editors. WHO Classification of Tumours of the Central Nervous System 5th ed Lyon. IARC Press; 2021. pp. 59–61.
-
- Rosenblum MK, Blumcke I, Ellison DW, Huse JT. Polymorphous low-grade neuroepithelial tumour of the young. In: Cree IA, Lokuhetty D, Peferoen LAN, White VA, editors. WHO Classification of Tumours of the Central Nervous System. 5th ed. Lyon: IARC Press; 2021. pp. 62–64.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous